Zhang Liang
No. 295, Xichang Road
Kunming, 650032, China
Kunming, 650032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A new dawn for Diabetic kidney disease: interleukin receptor antagonists.
Journal: Journal of translational medicine
Published: October 06, 2024
Analysis of research trends and hotspots in the primary treatment of end-stage renal disease.
Journal: International urology and nephrology
Published: July 11, 2024
Investigating the inflammatory mechanism of notoginsenoside R1 in Diabetic nephropathy via ITGB8 based on network pharmacology and experimental validation.
Journal: Molecular medicine (Cambridge, Mass.)
Published: June 04, 2024
Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis.
Journal: BMC endocrine disorders
Published: December 25, 2022
Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression.
Journal: Molecular immunology
Published: October 26, 2021
Negative regulation by proBDNF signaling of peripheral neurogenesis in the sensory ganglia of adult rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 17, 2020
Ginsenoside Rg1 improves cognitive capability and affects the microbiota of large intestine of tree shrew model for Alzheimer's disease.
Journal: Molecular medicine reports
Published: May 14, 2020
A negative feedback loop of H19/miR-675/EGR1 is involved in diabetic nephropathy by downregulating the expression of the vitamin D receptor.
Journal: Journal of cellular physiology
Published: December 21, 2018
Borrelia burgdorferi basic membrane protein A stimulates murine macrophage to secrete specific chemokines.
Journal: International journal of medical sciences
Published: April 13, 2018
Notoginsenoside R1 Promotes the Growth of Neonatal Rat Cortical Neurons via the Wnt/β-catenin Signaling Pathway.
Journal: CNS & neurological disorders drug targets
Published: January 01, 2018
Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Journal: CNS & neurological disorders drug targets
Published: January 19, 2017
Last Updated: 09/26/2026